Skip to main content
. 2021 Jul 9;12:655101. doi: 10.3389/fphar.2021.655101

FIGURE 8.

FIGURE 8

Schematic diagram summarizing the mechanisms by which CS-semi5 alleviates synovial inflammation, cartilage erosion and bone loss in RA. CS-semi5 effectively inhibits the NF-κB signaling pathway, including p65 nuclear translocation and phosphorylation of p-IKKα/β and p-NF-κB, both in vivo and in vitro. CS-semi5 also reduces TNF‐α and IL‐1β production by activated macrophages and blocks RANKL-trigged osteoclast differentiation of macrophages.